Severe lupus nephritis: importance of re-evaluating the histologic classification and the approach to patient care

被引:0
|
作者
Lewis, EJ
Schwartz, MM
Korbet, SM
机构
[1] Rush Presbyterian St Lukes Med Ctr, Nephrol Sect, Dept Med, Chicago, IL 60612 USA
[2] Rush Presbyterian St Lukes Med Ctr, Dept Pathol, Chicago, IL 60612 USA
关键词
systemic lupus erythematosus; lupus nephritis; segmental glomerulonephritis; diffuse prolyferative glomerulonephritis;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The histopathology of severe lupus glomerulonephritis comprises distinct patterns of injury which were initially defined by the World Health Organization Classification of 1982 as focal and segmental glomerulonephritis (category III), diffuse proliferative glomerulonephritis (category IV) and complex membranous glomerulonephritis (categories Vc, Vd). It is assumed that the morphologic abnormalities demonstrated in this classification represent distinctive differences in the mediation of the immune response which leads to a specific type of glomerular inflammation. In 1995 the World Health Organizational committee recommended a change in categorization of focal and segmental glomerulonephritis (class III) and diffuse proliferative glomerulonephritis (class IV), which would overlook the morphological differences between these categories and treat them as a continuum, recommending that biopsies classified as focal and segmental glomerulonephritis (category III) with involvement of greater than or equal to 50% of glomeruli be included into the diffuse proliferative glomerulonephritis category (category IV). Since the classification of severe lupus nephritis has significant impact on prognosis and the therapeutic approach to patients with this disease, it is the purpose of this review to critically re-examine the existing classification based on new insights into differences in morphologic features and long-term outcome.
引用
收藏
页码:223 / 227
页数:5
相关论文
共 50 条
  • [31] The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm
    Viswanathan Mohan
    Mark E. Cooper
    David R. Matthews
    Kamlesh Khunti
    Diabetes Therapy, 2019, 10 : 1 - 13
  • [32] The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm
    Mohan, Viswanathan
    Cooper, Mark E.
    Matthews, David R.
    Khunti, Kamlesh
    DIABETES THERAPY, 2019, 10 (Suppl 1) : S1 - S13
  • [33] Re-evaluating the design of seclusion rooms for psychiatric intensive care units
    Anthoney, Katrina
    INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, 2008, 17 : A1 - A1
  • [34] Long-term mizoribine intermittent pulse therapy, but not azathioprine therapy, attenuated histologic progression in a patient with severe lupus nephritis
    Tanaka, H.
    Tsugawa, K.
    Oki, E.
    Suzuki, K.
    Waga, S.
    Ito, E.
    CLINICAL NEPHROLOGY, 2007, 68 (03) : 198 - 200
  • [35] Thinking outside the box: re-evaluating the approach to penetrating cardiac injuries
    Stranch, E. W.
    Zarzaur, B. L.
    Savage, S. A.
    EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY, 2017, 43 (05) : 617 - 622
  • [36] Re-evaluating the role of energy efficiency standards: A behavioral economics approach
    Tsvetanov, Tsvetan
    Segerson, Kathleen
    JOURNAL OF ENVIRONMENTAL ECONOMICS AND MANAGEMENT, 2013, 66 (02) : 347 - 363
  • [37] Approach to Classification and Management of Childhood-Onset Lupus Nephritis
    Wenderfer, Scott E.
    Chang, Joyce
    Hicks, M. John
    CURRENT PEDIATRICS REPORTS, 2020, 8 (01) : 26 - 35
  • [38] Thinking outside the box: re-evaluating the approach to penetrating cardiac injuries
    E. W. Stranch
    B. L. Zarzaur
    S. A. Savage
    European Journal of Trauma and Emergency Surgery, 2017, 43 : 617 - 622
  • [39] Re-evaluating our approach to calcium and phosphorus management in dialysis patients
    Keith, DS
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (06) : 1331 - 1332
  • [40] Approach to Classification and Management of Childhood-Onset Lupus Nephritis
    Scott E. Wenderfer
    Joyce Chang
    M. John Hicks
    Current Pediatrics Reports, 2020, 8 : 26 - 35